Abstract
Activated Protein C resistance is a recently described clotting disorder, accounting for several previously undiagnosed thrombophilic states. Initially this defect had been associated with leg vein thromboses, but it is now recognised that other vascular beds are also prone to clotting in this disorder.
We report a case of acute proptosis in a patient with Activated Protein C resistance, due to cavernous sinus thrombosis.
Similar content being viewed by others
Article PDF
References
Dahlback B, Carlsson M, Svensson PJ . Familial thrombophilia due to a previously unrecognised mechanism characterised by poor anticoagulant response to activated protein C: prediction of a cofactor to activated protein C. Proc Natl Acad Sci USA 1993;90:1004–8.
Hirsh J, Raskob GE . Epidemiology and pathogenesis of venous thrombosis. J Am Coll Cardiol 1986;8:104B–13B.
Koster T, Rosendaal FR, de Ronde H, Briet E, Vandenbroucke JP, Bertina RM . Venous thrombosis due to poor anticoagulant response to activated protein C: Leiden thrombophilia study. Lancet 1994;342:1503–6.
Dahlback B, Hildebrand B . Inherited resistance to activated protein C is corrected by anticoagulant activity found to be a property of factor V. Proc Natl Acad Sci USA 1994;91:1396–400.
Voorberg J, Roelse J, Koopman R, et al. Association of idiopathic venous thrombo-embolism with single point mutation at Arg506 of factor V. Lancet 1994;343:1535–6.
Dhote R, Bachmeyer C, Horellou MH, Toulon P, Christoforov B . Central retinal vein thrombosis associated with resistance to activated protein C. Am J Ophthalmol 1995;120:388–9.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Comer, M., Kaushik, N. Acute proptosis in relation to activated protein C resistance: A case report. Eye 11, 115–117 (1997). https://doi.org/10.1038/eye.1997.23
Issue Date:
DOI: https://doi.org/10.1038/eye.1997.23